Temocaprilat (CAS 110221-53-9)
QUICK LINKS
Temocaprilat is a compound that functions as an angiotensin-converting enzyme (ACE) inhibitor. It acts by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing the production of angiotensin II. This leads to vasodilation and decreased aldosterone secretion, resulting in reduced blood pressure. At the molecular level, Temocaprilat binds to the active site of ACE, preventing the cleavage of angiotensin I and the subsequent formation of angiotensin II. By interfering with this enzymatic process, Temocaprilat disrupts the renin-angiotensin-aldosterone system, ultimately leading to its inhibitory effect on blood pressure. Temocaprilat′s mechanism of action may be useful for studying the physiological and pathophysiological roles of the renin-angiotensin system in experimental applications.
Temocaprilat (CAS 110221-53-9) References
- Trandolaprilat, an angiotensin-converting enzyme inhibitor, is not excreted in bile via an ATP-dependent active transporter (cMOAT). | Shionoiri, H., et al. 2001. Hypertens Res. 24: 235-40. PMID: 11409646
- Biliary excretion of taurolithocholate-sulfate and temocaprilat in cholestatic rats induced by bile duct-ligation and ethinylestradiol. | Takikawa, H., et al. 2002. Hepatol Res. 24: 136. PMID: 12270742
- Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. | Hasegawa, M., et al. 2003. J Pharmacol Exp Ther. 305: 1087-97. PMID: 12660303
- Converting enzyme inhibitor temocaprilat prevents high glucose-mediated suppression of human aortic endothelial cell proliferation. | Yasunari, K., et al. 2003. J Cardiovasc Pharmacol. 42 Suppl 1: S55-60. PMID: 14871030
- Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile. | Yasunari, K., et al. 2004. Cardiovasc Drug Rev. 22: 189-98. PMID: 15492767
- Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats. | Ito, N., et al. 2007. Am J Hypertens. 20: 792-9. PMID: 17586415
- Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study. | Vistoli, G., et al. 2009. Chem Biodivers. 6: 2092-100. PMID: 19937843
- Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways. | Kamioka, M., et al. 2010. J Atheroscler Thromb. 17: 590-600. PMID: 20379053
- Prediction of human intestinal absorption of the prodrug temocapril by in situ single-pass perfusion using rat intestine with modified hydrolase activity. | Nozawa, T. and Imai, T. 2011. Drug Metab Dispos. 39: 1263-9. PMID: 21474683
- Matrix metalloproteinase-2 inhibition by temocapril and its important role in peritoneal transport. | Yamamoto, D., et al. 2012. Clin Exp Pharmacol Physiol. 39: 864-8. PMID: 23013132
- Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). | Ishizuka, H., et al. 1997. J Pharmacol Exp Ther. 280: 1304-11. PMID: 9067317
- [Angiotensin-converting enzyme inhibitors: recent therapeutic aspect]. | Shionoiri, H., et al. 1997. Nihon Rinsho. 55: 2067-74. PMID: 9284425
- Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. | Ishizuka, H., et al. 1998. J Pharmacol Exp Ther. 287: 37-42. PMID: 9765319
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Temocaprilat, 1 mg | sc-220201 | 1 mg | $301.00 |